Tag: Motley Fool

The Vita Group Limited (ASX: VTG) share price is sliding today as the company plans to sell assets, giving more than half the profits back to its shareholders.

Vita is selling its retail information and communication technology segment to Telstra Corporation Ltd (ASX: TLS). The sale is expected to bring in a cool $110 million.

At the time of writing, the Vita share price is trading at 88 cents, 4.86% lower than its previous close.

Let’s take a closer look at today’s news from Vita.

Vita’s asset sale

The Vita share price is sinking on news it plans to sell its Telstra-branded stores and Sprout business for $110 million cash.

The cash consideration is still subject to a net working capital and net-debt adjustment. That will be finalised late this month.

Currently, Vita operates 104 Telstra-branded stores. The deal under which Vita operates the shops took a blow in February when Telstra announced it would fully own all Telstra stores by 2025.

It appears that Vita has run out in front, selling the portfolio, alongside its technological accessory brand, Sprout, to Telstra.

Of the $110 million to be received from the sale, Vita will keep $35 million. The remaining sale value – between $65 million and $75 million – is expected to be handed back to shareholders in the form of a special dividend.

The fully franked special dividend will be worth 39 cents to 45 cents per share and paid in 2 payments.

Vita advised that the $35 million kept in the company’s coffers would go towards growing its Artisan Aesthetic Clinics business.

The sale is subject to shareholder approval.

Additionally, Vita has confirmed that none of its employees will lose their jobs due to the sale. They will continue to be employed by the Vita People entity, which will be owned by Telstra.

Vita share price snapshot

Today’s dip is just the latest fall for the Vita share price, which has sunk 18.9% since the start of 2021. Vita shares are also 18.2% lower than this time last year.

The post Vita (ASX:VTG) share price sinks on asset sale and special dividend appeared first on The Motley Fool Australia.

More reading

• ASX 200 (ASX:XJO) midday update: Telstra buys Vita stores, Cochlear sinks
• Telstra (ASX:TLS) share price higher on Vita (ASX:VTG) deal
• 2 ASX shares just had a shocking month but could be bargains now

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Telstra Corporation Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3i5jGBp

The Pepinnini Minerals Ltd (ASX: PNN) share price has jumped out of the starting blocks on Friday and is now trading at 61 cents. This is 49% higher than its closing price yesterday.

In earlier trading, it hit an intraday high of 65 cents, up 58% and just 3 cents below its 52-week high.

The impressive surge in the Pepinnini share price has been spurred by the announcement of a new agreement today.

Here’s what’s happening.

What did Pepinnini Minerals announce?

The company advised that it has signed an agreement in Argentina with Litho Minera SA. This is a subsidiary of one of the world’s leading lithium manufacturers, Gangfeng Lithium (HKG: 1772).

Pepinnini entered into the agreement via its own subsidiary, Pepinnini SA for a pipeline to carry lithium brine from Ganfeng’s Mariana Project in Argentina.

This pipeline will basically run from Gangfeng’s project to Pepinnini’s Santa Ines project to the northwest.

It will be a “more environmentally friendly option than road for brine transport”, according to the company.

The pair will also carry out an induced polarisation (IP) geophysical survey on 11 kilometres of Santa Ines. Both parties will cover the survey’s costs.

Pepinnini said the survey will be a useful interpretive tool for the pair. It will begin in October and run for 12 days.

According to a statement released by Pepinnini:

For Pepinnini it will be an exploration tool for copper-gold mineralisation targets for drill testing while it will give Ganfeng reassurance that the pipeline trace will not require relocation in the event of a mineral discovery.

Investors have bought on the news and are continuing to drive the Pepennini share price higher this afternoon.

Pepinnini share price snapshot

It’s been a rocky road for the Pepinnini share price, although it has climbed 74% since 1 January.

Over the past month alone, Pepinnini shares have gained 96% and show no sign of slowing down today.

Study results out of its lithium brine project in Chile have propelled the Pepinnini share price higher this week, too.

The share price is up 408% over 12 months. This compares to about 25% for the S&P/ASX 200 Index (ASX: XJO).

The post The Pepinnini (ASX:PNN) share price jumps 58% on new agreement appeared first on The Motley Fool Australia.

More reading

• Pepinnini Minerals (ASX:PNN) share price rockets 40% on lithium update

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3kByyZV

It has been another busy week for Australia’s top brokers. This has led to the release of a large number of broker notes.

Three broker buy ratings that have caught my eye are summarised below. Here’s why brokers think these ASX shares are in the buy zone:

AGL Energy Limited (ASX: AGL)

According to a note out of Ord Minnett, its analysts have upgraded this energy company’s shares to a buy rating with a trimmed price target of $7.55. The broker made the move in response to a sharp pullback by the company’s shares this year. Ord Minnett notes that this leaves AGL’s shares trading below its valuation of just its retail business. The AGL Energy share price is changing hands for $6.01 on Friday.

Bapcor Ltd (ASX: BAP)

A note out of Citi reveals that its analysts have upgraded this auto parts company’s shares to a buy rating with an $8.25 price target. Citi upgraded the company’s shares on valuation grounds after a sizeable post-results pullback. In addition, the broker is positive on Bapcor’s outlook due to its store rollout plans and its belief that it will benefit from the opening up of New South Wales and Victoria from lockdowns in the near future. The Bapcor share price is fetching $7.51 this afternoon.

Brickworks Limited (ASX: BKW)

Another note out of Citi reveals that its analysts have retained their buy rating and lifted their price target on this building products company’s shares to $30.00. This follows the release of a full year result that was ahead of both the broker’s expectations and the market consensus estimate. Looking ahead, the broker is confident in its outlook and has upgraded its forecasts to reflect this. The Brickworks share price is trading at $25.25 on Friday afternoon.

The post Brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.

More reading

• 2 fantastic ASX growth shares tipped as buys
• 2 ASX shares that could be buys for both growth and dividends
• Why the embattled AGL (ASX:AGL) share price is surging higher today
• Which ASX 300 shares are the top movers today?
• Why Bapcor, Brickworks, News Corp, & Premier Investments are rising

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Brickworks. The Motley Fool Australia owns shares of and has recommended Bapcor and Brickworks. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3i2Ag57

Shares in Dimerix Ltd (ASX: DXB) are soaring today, shooting up 9% in early trade. At the time of writing, the Dimerix share price has retreated slightly and is now trading at 30 cents apiece, up 7.4%.

Below we take a look at the clinical-stage biopharmaceutical company’s announcement on COVID-19 treatment that looks to be driving investor interest.

What COVID-19 announcement did Dimerix make?

The Dimerix share price is rocketing after the company reported that Indian regulatory agency – the Central Drugs Standard Control Organization (DCGI) – has formally recommended approval of the DMX-200 clinical study in COVID-19 patients.

DMX-200 is Dimerix’s lead drug candidate, developed to potentially treat focal segmental glomerulosclerosis (FSGS), respiratory problems relating to COVID-19, and diabetic kidney disease.

According to the release, numerous clinical sites in India are ready to start recruitment in the feasibility/Phase 3 clinical study of DMX-200 to treat COVID-related respiratory complications.

The DCGI regulatory approval was the final one required before launching the CLARITY 2.0 study. Dimerix expects the first of what may be 600 participants to be dosed inside the next few weeks. The company is still awaiting receipt of the approval permit to move forward.

What did management say?

Commenting on the progress, Dimerix’s CEO Nina Webster said:

We are extremely pleased to be in a position to potentially treat COVID-19 patients suffering debilitating respiratory complications, through both the CLARITY 2.0 study as well as the REMAP-CAP study currently recruiting in Europe…

[I]f DMX-200 does show benefit in respiratory complications associated with COVID-19, it may also show benefit in respiratory complications associated with other infections too, such as pneumonia and influenza. Thus, this provides an opportunity that could extend well beyond the impact of COVID-19.

The study is being led by Professor Meg Jardine, director of the NHMRC Clinical Trials Centre at The University of Sydney, along with Professor Vivek Jha and The George Institute for Global Health India.

Dimerix share price snapshot

With today’s intraday gains factored in, the Dimerix share price is up 39% over the past 12 months. By comparison the All Ordinaries Index (ASX: XAO) gained 27% over that same period.

Dimerix shares are currently trading 2% higher than this time last month.

The post Dimerix (ASX:DXB) share price soars 9% on COVID-19 news appeared first on The Motley Fool Australia.

More reading

• The Dimerix (ASX:DXB) share price is up 3% on Thursday

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3u9M8qt

The Evolution Mining Ltd (ASX: EVN) share price has tumbled again today, hitting a new 52-week low.

The plunge has come despite an announcement that the company’s director bought shares in the company yesterday afternoon.

At the time of writing, the Evolution share price is $3.64, 3.19% lower than its previous close.

However, earlier today, Evolution’s shares were trading for $3.60 – a new 52-week low.

Let’s take a look at the latest news from the gold producer and what might be dragging on its share price.

What’s driving Evolution’s stock down today?

The Evolution share price is in the red again today following its 1% dip yesterday.

Today’s drop coincides with a falling gold price. Right now, the price of gold is down 0.01% to US$1749.60 an ounce.

According to Kitco, sentiment in the United States’ manufacturing and mining segment has seen the gold price “unable to find any bullish traction” lately.

Even news of a director purchase hasn’t been enough to boost the Evolution share price.

Less than 90 minutes before the ASX closed on Thursday, Evolution released news its director, Vicky Bins, had purchased 13,140 shares in Evolution through an indirect trust account for $49,932.

Generally, a director buying into a company is seen as a sign they have confidence in the business and that the company’s stock will gain in the future.

However, the positive indication hasn’t bolstered the market’s confidence in Evolution’s stock, the value of which has now fallen 9.7% since this time last month.

Evolution share price snapshot

2021 hasn’t been a good year for the Evolution share price.

It has fallen a whopping 30% since the start of this year. It is also 34% lower than it was this time last year.

The company has a market capitalisation of around $9.9 billion, with approximately 1.8 billion shares outstanding.

The post Evolution Mining (ASX:EVN) share price hits 52-week low appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Thursday
• 5 things to watch on the ASX 200 on Wednesday
• ASX 200 rebounds into positive territory led by energy and materials shares
• 5 things to watch on the ASX 200 on Tuesday
• Why ASX 200 gold shares are sinking on Friday

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3i3365c

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week with a decline. At the time of writing, the benchmark index is down 0.4% to 7,340.1 points.

Four ASX shares that are not letting that hold them back are listed below. Here’s why they are rising:

Computershare Ltd (ASX: CPU)

The Computershare share price is up 5.5% to $17.89. This is despite there being no news out of the share registry company. However, speculation that the US Federal Reserve could raise interest rates sooner than anticipated may have given its shares a boost. Low rates have been weighing on Computershare’s margins.

Lake Resources N.L. (ASX: LKE)

The Lake Resources share price is up 8.5% to 63 cents. Investors have been buying this lithium explorer’s shares this week after it announced a partnership with Lilac Solutions. This partnership is for technology and funding to develop Lake Resource’s Kachi Lithium Brine Project in Argentina. The Lake Resources share price is now up almost 700% in 2021.

Premier Investments Limited (ASX: PMV)

The Premier Investments share price is up almost 3% to $28.40. This morning the team at Bell Potter responded positively to the retail giant’s full year results. The broker upgraded its shares to a buy rating with a price target of $31.25. “While we expect a rebase in FY22 earnings, we believe this is already priced in & we now look beyond this and see the resumption of solid growth from FY23 onwards. With an implied Just Group EV/EBITDA (pre-AASB16) ~10x, we upgrade from Hold to Buy,” it added.

Woodside Petroleum Limited (ASX: WPL)

The Woodside Petroleum share price is up 2.5% to $22.33. Investors have been buying Woodside and other energy shares today after oil prices charged higher overnight. Traders were buying oil after growing fuel demand and a draw in U.S. crude inventories led to tight supplies.

The post Why Computershare, Lake, Premier Investments, & Woodside shares are rising appeared first on The Motley Fool Australia.

More reading

• ASX 200 (ASX:XJO) midday update: Telstra buys Vita stores, Cochlear sinks
• Why ASX 200 energy shares are trouncing the index today
• 3 more small-cap ASX shares with a competitive edge
• Brokers give their verdict on the Premier Investments (ASX:PMV) share price
• How do you value the Woodside Petroleum (ASX:WPL) share price?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Premier Investments Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/2XYVolE

Here are 3 ASX shares to keep an eye on today, as they’re likely to fall for no initially obvious reason. Of course, they are 3 of the shares that will be trading ex-dividend today.

As most market watchers will be aware, shareholders who buy into a company after its ex-dividend date aren’t eligible for its upcoming dividend. Instead, the next dividend will go to the seller of any shares traded from today onwards.

So, which ASX shares might struggle as they surpass that milestone today? Let’s take a look.

ASX shares trading ex-dividend today

Sigma Healthcare Ltd (ASX: SIG)

Financial year 2021 (FY21) was productive for Sigma. The company increased its revenue by 5.5% and upped its underlying net profit after tax by 23.7% compared to FY20.

As a result, the pharmaceutical wholesaler, distributor, and pharmacy franchisor is giving its shareholders a 1 cent fully franked dividend. That leaves Sigma with a dividend yield of around 1.59%.

The company’s upcoming dividend is payable on 8 October.

The Sigma share price has fallen 1.64% to trade at 60 cents at the time of writing.

However, that’s not the only news that could be moving the sigma share price today. The company has announced a new CEO will be taking the reins in February 2022.

Atlas Arteria Group (ASX: ALX)

Atlas posted incredible results for FY21, which included an 845% increase to its net profit after tax (excluding notable items) compared to that of FY20.

As a result, the toll road operator provided a 15.5 cent unfranked dividend to its shareholders, giving it an impressive 3.61% dividend yield.

The company’s dividend will be paid on 5 October.

So far today, the Atlas share price has fallen 3.48% on the back of its ex-dividend date. It is currently trading at $6.65.

BSP Financial Group Ltd (ASX: BFL)

Weathering what could have been an ex-dividend-induced storm is the BSP Financial share price, which hasn’t moved at all today.

BSP Financial is set to provide its shareholders with a 1.5 cent dividend (converted from Papua New Guinean Kina at the current exchange rate of AUD$1 to PGK2.56).

The dividend follows from the company’s productive FY21, over which it increased its net profit after tax by 17.6% on that of FY20.

It will be paid on 18 October.

The post These 3 ASX shares are going ex-dividend today appeared first on The Motley Fool Australia.

More reading

• Sigma (ASX:SIG) share price unmoved by new CEO appointment
• Why APA, Kathmandu, Nickel Mines, & Sigma shares are dropping
• Why Atlas Arteria, Baby Bunting, De Grey Mining, & New Hope are pushing higher
• Sigma (ASX:SIG) share price sinks 7% on half year update and guidance downgrade
• Which ASX shares are ending the week as the biggest movers today?

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3o1VWlv

The Readytech Holdings Ltd (ASX: RDY) share price has stepped into the green during morning trade and is now trading 1.5% higher at $3.38.

Earlier, it was doing even better at $3.55, which is a new 52-week high for the people management software provider.

There’s no market-sensitive news out of the company today. Nonetheless, the shares have exploded from a previous low of $2.53 on 23 August.

Let’s take a closer look at what’s behind this momentum.

What’s fuelling this growth?

The Readytech share price has been on the move ever since the company reported its FY21 earnings late last month.

In its report, the company recognised a 27% increase in revenue to $50 million. A key takeaway was its 45% net profit after tax (NPAT) gain to $2.1 million. Impressively, 87% of its revenue came from subscription contracts in FY21 and revenue retention was 96%.

It also saw an almost $7,000 increase in average revenue per customer to $35,000 for the year, coupled with an 11% increase in marketing spend.

Let’s not forget the company’s acquisition of software business Open Office back in May on an $80 million valuation.

On this positive backdrop, Readytech forecasts revenue growth in the mid-teens and an EBITDA margin of 36%-38% in FY22. Longer-term, it hopes to generate $125 million in revenue by FY26, which is a cumulative 150% increase on FY21.

Investors appear to have bought in on Readytech’s growth narrative. They have bumped the Readytech share price 40% higher since its earnings release. In the first 5 days after its announcement, the Readytech share price climbed 25%.

This appears to be the main tailwind behind the company’s shares over the past few weeks.

Readytech share price snapshot

The Readytech share price has climbed 61% this year to date and 86% over the past 12 months.

Readytech shares are up another 9% in the past week alone.

It is outpacing the S&P/ASX 200 index (ASX: XJO) which has risen about 25% over the past year.

The post Readytech (ASX:RDY) share price reaches 52-week high appeared first on The Motley Fool Australia.

More reading

• Is the CSL (ASX:CSL) share price in the buy zone?
• What were the biggest movers on the Nasdaq 100 (ASX:NDQ) overnight?
• ASX 200 (ASX:XJO) midday update: Telstra buys Vita stores, Cochlear sinks
• Sigma (ASX:SIG) share price unmoved by new CEO appointment
• Why ASX 200 energy shares are trouncing the index today

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Readytech Holdings Ltd. The Motley Fool Australia has recommended Readytech Holdings Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3lTSkPN

If you’re looking for blue chip shares to buy, then the CSL Limited (ASX: CSL) share price could be worth considering.

The biotech giant is one of the biggest companies on the local share market and has been tipped as a buy by a leading broker.

Strong businesses and long term growth potential

CSL is the biotech company behind the CSL Behring and Seqirus business. The former is a specialist in plasma-based products, whereas the latter specialises in vaccines.

These two businesses have been driving solid sales and profit growth for CSL in recent years. And this looks set to continue long into the future thanks to increasing demand for its core therapies and vaccines, and its lucrative research and development (R&D) pipeline.

In respect to the latter, each year CSL reinvests approximately 11% of its sales into its R&D activities. This ensures that the company has a pipeline of products that have the potential to generate millions and potentially even billions of dollars in sales each year.

In its pipeline at present are CSL112 and clazakizumab. CSL112 is a novel apolipoprotein A-I infusion therapy that has been shown to have an immediate and significant impact on the ability to remove cholesterol from arteries. Whereas clazakizumab is being developed to treat kidney transplant rejection. This product alone could generate peak sales of US$5.4 billion according to analysts.

Is the CSL share price in the buy zone?

The team at Morgans are positive on the CSL share price. A recent note reveals that they currently have an add rating and $324.40 price target on its shares.

It commented: “We view CSL as a core holding and best positioned among its peers to meet growing patient demand, but the near term remains challenged, with timing uncertainty around a full recovery in plasma collections and increasing costs.”

This could make it worth considering the CSL share price with a patient and long term view.

The post Is the CSL (ASX:CSL) share price in the buy zone? appeared first on The Motley Fool Australia.

More reading

• How has the CSL (ASX:CSL) share price performed since FY21 results?
• 3 experts pick 3 ASX shares to rocket in next 12 months
• Why is the ASX All Ordinaries (ASX:XAO) struggling lately?
• The CSL (ASX:CSL) share price has had a good 6 months. Is it a buy?
• 2 high quality ASX 50 shares named as buys

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/2XDhSZ3

Investors in the Betashares Nasdaq 100 ETF (ASX: NDQ) are probably keen to know what were the biggest movers of the NASDAQ 100 overnight.

At the time of writing, units in the exchange traded fund (ETF) are trading for $33.45 – down 0.06%. Overnight, however, the NASDAQ 100 ended its trading day up 0.92%.

So, what were the biggest movers overnight?

Let’s take a closer look.

What is NDQ invested in?

As the name of the ETF suggests, NDQ is invested in the 100 largest companies listed on the New York based tech-heavy stock exchange, such as Apple Inc (NASDAQ: AAPL), Amazon.com, Inc (NASDAQ: AMZN), and Facebook, Inc (NASDAQ: FB).

Non-tech shares the ETF (and therefore the shareholder) are invested in include PepsiCo, Inc. (NASDAQ: PEP), Costco Wholesale Corporation (NASDAQ: COST), and healthcare company Moderna Inc (NASDAQ: MRNA).

What moved the Nasdaq-100?

According to Nasdaq, the most prominent movers in early trade included biotech company Biogen Inc (NASDAQ: BIIB) – up 3.1%, and Pinduoduo Inc (NASDAQ: PDD) – down 1.2%.

Other prominent movers earlier in the day include Moderna – up 2.8%, and Okta Inc (NASDAQ: OKTA) – down 1%.

By the end of the day these were the 3 biggest gainers:

• Marriott International Inc (NASDAQ: MAR) – up 3.82%.
• Moderna Inc – up 3.15%.
• Booking Holdings Inc (NASDAQ: BKNG) – up 2.88%.

And these were the 3 heaviest fallers on the index by the end of the day:

• Seagen Inc (NASDAQ: SGEN) – down 1.74%.
• Charter Communications Inc (NASDAQ: CHTR) – down 1.28%.
• Okta Inc – down 0.80%.

Let’s see if NDQ follows the NASDAQ 100’s lead and ends today higher.

NDQ share price snapshot

Over the past 12 months, shares in the ETF have increased 31.9%. This is greater than the S&P/ASX 200 Index (ASX: XJO) but less than the actual NASDAQ 100 composite (by about 9 percentage points). It is, however, roughly matching its namesake’s performance since the beginning of the year – both up about 21%.

The post What were the biggest movers on the Nasdaq 100 (ASX:NDQ) overnight? appeared first on The Motley Fool Australia.

More reading

• Expert reveals top pandemic ETF play – up 58% in 12 months
• 2 very high quality ASX shares to own
• 2 top ASX ETFs that give investors access to Wall Street’s best tech shares
• 2 popular ETFs for ASX investors to buy
• 3 top quality ETFs for ASX investors

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to its CEO, Mark Zuckerberg, is a member of The Motley Fool’s board of directors. Motley Fool contributor Marc Sidarous owns shares of BETANASDAQ ETF UNITS. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Amazon, Apple, BETANASDAQ ETF UNITS, Booking Holdings, Costco Wholesale, and Facebook. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Moderna Inc. and has recommended the following options: long January 2022 $1,920 calls on Amazon, long March 2023 $120 calls on Apple, short January 2022 $1,940 calls on Amazon, and short March 2023 $130 calls on Apple. The Motley Fool Australia owns shares of and has recommended BETANASDAQ ETF UNITS. The Motley Fool Australia has recommended Amazon, Apple, Booking Holdings, and Facebook. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3i0bT7O